Compare Corteva Inc. Common Stock (CTVA) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corteva Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.22 (market cap $9.17B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Corteva Inc. Common Stock pays a 5.24% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| CTVA | HALO | |
|---|---|---|
Market Cap | $9.17B | $12.58B |
Volume | 35,183,471 | 2,179,278 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $115.22 |
52-Week Low | $11.92 | $61.63 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $11.68B | $14.49B |
Dividend Yield | 5.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corteva Inc. Common Stock
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
